Loading clinical trials...
Loading clinical trials...
Collecting information regarding adverse events from patients on treatment with anastrazole with early stage breast cancer
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
AstraZeneca
NCT05774951 · Breast Cancer, Early Breast Cancer
NCT07616427 · HR+/HER2+ Early Breast Cancer
NCT07379918 · Breast Cancer (Early Breast Cancer), Breast Cancer Survivors, and more
NCT06797531 · HR+/HER2- Early Breast Cancer
NCT07331506 · Breast Cancer Detection, Breast Cancer Early Stage Breast Cancer (Stage 1-3), and more
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions